• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Environ Toxicol Pharmacol . Dual Function of Sialic Acid in Gastrointestinal SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Environ Toxicol Pharmacol


. 2020 Jun 17;103436.
doi: 10.1016/j.etap.2020.103436. Online ahead of print.
Dual Function of Sialic Acid in Gastrointestinal SARS-CoV-2 Infection


Ayse Basak Engin[SUP] 1 [/SUP], Evren Doruk Engin[SUP] 2 [/SUP], Atilla Engin[SUP] 3 [/SUP]



Affiliations

Abstract

Recent analysis concerning the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- angiotensin converting enzyme (ACE) receptor interaction in enterocytes, the definition of gut-lung axis, as well as the molecular basis of sialic acid-related dual recognition concept in gastrointestinal SARS-CoV-2 infection, have brought a new perspective to potential therapeutic targets. In this review evolving research and clinical data on gastrointestinal SARS-CoV-2 infection are discussed in the context of viral fusion and entry mechanisms, focusing on the different triggers used by coronaviruses. Furthermore, it is emphasized that the viral spike protein is prevented from binding gangliosides, which are composed of a glycosphingolipid with one or more sialic acids, in the presence of chloroquine or hydroxychloroquine. In gastrointestinal SARS-CoV-2 infection the efficiency of these repositioned drugs is debated.

Keywords: ACE2; SARS-CoV-2; chloroquine; faecal-oral route; gut-lung axis; sialic acid.
 
Back
Top Bottom